You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Anti-tumor activity of novel fused pyrimidine and benzodiazepine analogues
- At: Glasgow (Scotland) (2018)
- Type: Poster
- Poster code: POS-DDD-009
- By: A.SHALABY, Aya (Faculty of pharmacy, Mansoura University, Mansoura, Egypt)
- Co-author(s):
Heba M. El-Hadedy1, Aya A. Shalaby* 1, Ghada S. Hassan2, Shahenda M. El-Messery2, Ahmed R. Elsheakh3
1Faculty of Pharmacy, 2Department of pharmacutical organic chemistry, Faculty of pharmacy, 3Department of pharmacology and toxocology, Faculty of pharmacy, Mansoura University, Mansoura, Egypt
- Abstract:
Background
In Egypt,
- The most common cancer in women is breast cancer.
- Unfortunately, it is also the 2nd leading cause of cancer death in women.
A series of benzo[b]pyrido[4,3-e][1,4]diazepines and benzo[4,5]thiazolo[3,2-a]pyrido[4,3-d]pyrimidines has been synthesized and tested for their in vitro antitumor activity against MCF -7 breast
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login